Suppr超能文献

SARS-CoV-2 再感染:来自印度的流行病学定义的制定。

SARS-CoV-2 re-infection: development of an epidemiological definition from India.

机构信息

Division of Epidemiology & Communicable Diseases, ICMR Headquarters, Delhi, India.

Division of Information, Systems and Research Management, ICMR Headquarters, Delhi, India.

出版信息

Epidemiol Infect. 2021 Mar 26;149:e82. doi: 10.1017/S0950268821000662.

Abstract

The current investigation was conducted with the objective to develop an epidemiological case definition of possible severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection and assess its magnitude in India. The epidemiological case definition for SARS-CoV-2 re-infection was developed from literature review of data on viral kinetics. For achieving second objective, the individuals who satisfied the developed case definition for SARS-CoV-2 re-infection were contacted telephonically. Taking available evidence into consideration, re-infection with SARS-CoV-2 in our study was defined as any individual who tested positive for SARS-CoV-2 on two separate occasions by either molecular tests or rapid antigen test at an interval of at least 102 days with one negative molecular test in between. In this archive based, telephonic survey, 58 out of 1300 individuals (4.5%) fulfilled the above-mentioned definition; 38 individuals could be contacted with healthcare workers (HCWs) accounting for 31.6% of the cases. A large proportion of participants was asymptomatic and had higher Ct value during the first episode. While SARS-CoV-2 re-infection is still a rare phenomenon, there is a need for epidemiological definition of re-infection for establishing surveillance systems and this study contributes to such a goal.Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) re-infection is an emerging concern and there is a need to define it. Therefore, working epidemiological case definition for re-infection was developed and its magnitude was explored via archive-based, telephonic survey. Re-infection with SARS-CoV-2 was defined as two positive tests at an interval of at least 102 days with one interim negative test. Thirty-eight of the 58 eligible patients could be contacted with 12 (31.6%) being HCWs. Majority of the participants were asymptomatic and had higher Ct value during their first episode. To conclude, a working epidemiological case definition of SARS-CoV-2 re-infection is important to strengthen surveillance. The present investigation contributes to this goal and records reinfection in 4.5% of SARS-CoV-2 infected individuals in India.

摘要

目前的研究旨在制定一种可能的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)再感染的流行病学病例定义,并评估其在印度的流行程度。SARS-CoV-2 再感染的流行病学病例定义是从病毒动力学数据的文献综述中制定的。为了实现第二个目标,通过电话联系符合 SARS-CoV-2 再感染制定病例定义的个体。根据现有证据,本研究中 SARS-CoV-2 的再感染定义为任何个体通过分子检测或快速抗原检测在至少 102 天的间隔内两次检测呈 SARS-CoV-2 阳性,两次检测之间有一次阴性分子检测。在这项基于存档的电话调查中,1300 名个体中有 58 名(4.5%)符合上述定义;可以联系到 38 名个体,其中包括 31.6%的病例的医护人员(HCWs)。大多数参与者无症状,且首次发病时 Ct 值较高。虽然 SARS-CoV-2 再感染仍然是一个罕见的现象,但需要对再感染进行流行病学定义,以建立监测系统,本研究为此目标做出了贡献。严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)再感染是一个新出现的问题,需要对其进行定义。因此,制定了再感染的工作流行病学病例定义,并通过基于存档的电话调查探索了其流行程度。SARS-CoV-2 的再感染定义为至少 102 天间隔的两次阳性检测,中间有一次阴性检测。符合条件的 58 名患者中有 38 名可以联系到,其中 12 名(31.6%)是 HCWs。大多数参与者无症状,且首次发病时 Ct 值较高。总之,制定 SARS-CoV-2 再感染的工作流行病学病例定义对于加强监测非常重要。本研究为此目标做出了贡献,并记录了印度 SARS-CoV-2 感染个体中有 4.5%发生再感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c520/8027559/57e0b5f4410c/S0950268821000662_fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验